The AD-CSF-Index Discriminates Alzheimer's Disease Patients from Healthy Controls: A Validation Study-Reference-Cited by-同舟云学术

The AD-CSF-Index Discriminates Alzheimer's Disease Patients from Healthy Controls: A Validation Study

Published:2013-06-04 Issue:1 Volume:36 Page:67-77
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Molinuevo Jose L.¹²³,Gispert Juan Domingo³,Dubois Bruno⁴,Heneka Michael T.⁵,Lleo Alberto⁶,Engelborghs Sebastiaan⁷,Pujol Jesús⁸,de Souza Leonardo Cruz⁴,Alcolea Daniel⁶,Jessen Frank⁹,Sarazin Marie⁴,Lamari Foudil¹⁰,Balasa Mircea¹,Antonell Anna¹²,Rami Lorena¹²

Affiliation:

1. Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Barcelona, Spain

2. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain

3. BarcelonaBeta Brain Research Centre, Pasqual Maragall Foundation, Barcelona, Spain

4. Alzheimer Institute, Research and Resource Memory Centre, AP-HP, Pitié-Salpêtrière Hospital, Paris, France

5. Neurology Department, University of Bonn, Germany

6. Neurology Department, Hospital Sant Pau, Barcelona, CIBERNED, Spain

7. Reference Centre for Biological Markers of Dementia (BIODEM), University of Antwerp, Antwerp, Belgium

8. CRC-Mar, Hospital del Mar, CRC Corporació Sanitària, Barcelona, Spain

9. Department of Psychiatry, University of Bonn, Bonn, Germany

10. Department of Metabolic Biochemistry, AP-HP, Pitiá-Salpêtrière Hospital, Paris, France

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell-free RNA signatures predict Alzheimer’s disease;iScience;2023-12

2. Inflammation as common link to progressive neurological diseases;Archives of Toxicology;2023-11-15

3. How far is the goal of applying β-amyloid in cerebrospinal fluid for clinical diagnosis of Alzheimer’s disease with standardization of measurements?;Clinical Biochemistry;2023-02

4. Fluid-Based Biomarkers of Alzheimer’s Disease;Biomarkers in Neuropsychiatry;2023

5. Estudio CORCOBIA: determinación de puntos de corte de biomarcadores de enfermedad de Alzheimer en LCR en una cohorte clínica;Neurología;2022-09